MS-N327 · Yoga Nidra · Psychological distress · Active cancer treatment · Human evidence · Appraised 13 November 2026
Can a month of twice-daily Yoga Nidra improve distress and quality of life during cancer treatment?
Evidence at a glance
- Evidence label: Small randomized trial; broad positive signals with high risk of imprecision and multiplicity
- Benefit: Distress and several quality-of-life domains favored Yoga Nidra after one month.
- Certainty: Low because only 40 participants were randomized and many outcomes were tested.
- Risk: No specific adverse-event data were verified; relaxation may be adapted for mobility, pain, fatigue or trauma sensitivity.
What was studied
Forty adults aged 25–55 receiving chemotherapy, radiotherapy, hormone therapy or immunotherapy were randomized to Yoga Nidra or control, 20 per arm. The intervention was 25 minutes twice daily, five days weekly for one month.
What the evidence found
The intervention favored control for distress, global health, emotional and social function, fatigue, pain, dyspnea and diarrhea. Post-hoc comparisons remained significant for distress, emotional function and dyspnea. Absolute effect sizes and confidence intervals were not available in the abstract.
How to interpret it
The small heterogeneous sample, intensive practice schedule and multiple outcomes increase false-positive and generalizability concerns. Durability, adherence, adverse events, missing data and clinically meaningful response proportions were not verified.
These outcomes concern symptoms, distress, sleep or supportive care. They do not establish tumor response, delayed recurrence, progression-free survival or longer overall survival.
Practical safety context
Yoga Nidra is usually performed lying or seated, but positioning may need adjustment for pain, neuropathy, surgical restrictions or breathlessness. Guided language should be trauma-sensitive. It is symptom support, not a cancer treatment, and should not delay evaluation of pain, diarrhea or dyspnea.
Questions for the care team
- Is the proposed recording and schedule realistic during my treatment?
- Can positioning and language be adapted to my symptoms and preferences?
- Which outcome are we trying to improve, and how will we know if it is meaningful?
Funding and conflicts
The authors declared no competing financial interests. Complete funding details were not verified in the abstract.
Sources
Last literature search: 13 November 2026. Record appraisal: 13 November 2026. Only the abstract and bibliographic record were fully accessible; unreported fields remain not verified. This page is educational and does not replace individualized medical advice.
